Device Trial Radar · NCT07047924
A Clinical Trial Assessing the Safety and Effectiveness of Orthokeratology Lenses in Patients With Myopia and Myopic Astigmatism
Last checked: Nov 19, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Jul 1, 2025
Primary completion
Dec 1, 2026
Study completion Dec 1, 2026
Sponsor
- Lead sponsor
- Menicon Co., Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 2, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 6 years, up to 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-centre, single-arm clinical trial to evaluate the effectiveness and safety of MCOK-01 lenses in patients with myopia and myopic astigmatism who need dioptric correction. A maximum number of 220 participants are planned to be enrolled , with a minimum of 150 planned to complete the trial (30% dropout). All participants will be enrolled in Australia. Enrolled participants will wear the lenses every night for up to 12 months, removing them upon waking. 8 follow up visits will be completed during treatment, after: 1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months, 9 months and 12 months of wearing the lenses.
Conditions
- Myopia
- Myopic Astigmatism
Interventions
MCOK-01Device
The investigational device is a Rigid Gas Permeable contact lenses for orthokeratology. MCOK-01 applied the reverse geometry design and adopted the lens material which possesses the highest oxygen permeability among all the materials for orthokeratology lens.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Lines of improvement of monocular uncorrected distance visual acuityTime frame: 12-months following enrolment
- Proportion of eyes achieved uncorrected distance visual acuity of ≤0.30 logMAR, ≤0.20 logMAR, ≤0.10 logMAR, and ≤0.00 logMARTime frame: 1 month, 3 months, 6 months, 9 months, and 12 months following enrolment
- A level of attempted versus achieved reduction in manifest refractive errorTime frame: 12 months following enrolment
4 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Eyecare Kids
Hillsdale, New South Wales, Australia
UNSW School of Optometry and Vision Science
Sydney, New South Wales, Australia
Queensland University of Technology Optometry and Vision Science
Kelvin Grove, Queensland, Australia
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.